Menu
Back to User profile » Dr Wenjin Yin
Papers published by Dr Wenjin Yin:
A single-nucleotide polymorphism of the beta 2-adrenergic receptor gene can predict pathological complete response to taxane- and platinum-based neoadjuvant chemotherapy in breast cancer
Du Y, Yan T, Zhou L, Yin W, Lu J
Breast Cancer: Targets and Therapy 2018, 10:201-206
Published Date: 27 November 2018
Clinical significance of quantitative HER2 gene amplification as related to its predictive value in breast cancer patients in neoadjuvant setting
Wu Z, Xu S, Zhou L, Yin W, Lin Y, Du Y, Wang Y, Jiang Y, Yin K, Zhang J, Lu J
OncoTargets and Therapy 2018, 11:801-808
Published Date: 15 February 2018
Expression profile analysis of long noncoding RNA in ER-positive subtype breast cancer using microarray technique and bioinformatics
Peng J, Zhang L, Yuan CW, Zhou LH, Xu SG, Lin YP, Zhang J, Yin WJ, Lu JS
Cancer Management and Research 2017, 9:891-901
Published Date: 14 December 2017
Optimizing the treatment of bevacizumab as first-line therapy for human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer: an updated meta-analysis of published randomized trials
Li C, Xiang A, Chen X, Yin K, Lu J, Yin W
OncoTargets and Therapy 2017, 10:3155-3168
Published Date: 27 June 2017
Single-nucleotide polymorphism in microRNA-binding site of SULF1 target gene as a protective factor against the susceptibility to breast cancer: a case-control study
Zhou Q, Jiang Y, Yin W, Wang Y, Lu J
OncoTargets and Therapy 2016, 9:2749-2757
Published Date: 9 May 2016
Clinical significance of locoregional and systemic treatment in operable high-risk breast cancer patients with more than four positive axillary lymph nodes
Yin K, Zhou L, Shao Z, Yin W, Lu J
OncoTargets and Therapy 2015, 8:2665-2673
Published Date: 21 September 2015